title: [Effect of continuous blood purification on endothelial cell function in patients with severe sepsis].
abstract: OBJECTIVE
  To investigate the effect of continuous blood purification (CBP) in patients with severe sepsis, and to evaluate the change in endothelial cell function in patients with severe sepsis during CBP therapy.
  
  
  METHODS
  According to random principle, 45 patients were divided into control group (n=22) and CBP group (n=23). All patients of both groups received routine treatment according to international guidelines 2008 for management of severe sepsis, but the patients in the CBP group also received continuous veno-venous hemofiltration (CVVH) for 72 hours, the ultrafiltrate volume was 40 ml×kg(-1)×h(-1). Blood gas analysis was done before and 24 hours and 72 hours after CVVH therapy. The activated protein C (APC), soluble intercellular adhesion molecule-1 (sICAM-1) and von Willebrand factor (vWF) were measured. Also the length of stay in intensive care unit (ICU), time of mechanical ventilation, and death rate of patients in 28 days were observed.
  
  
  RESULTS
  Compared with control group, the length of stay in ICU (days) and length of use of ventilator (days) in CBP group were shorter (9.12±3.07 vs. 11.64±4.82, 5.52±3.48 vs. 8.02±5.25, both P<0.05), and the death rate in 28 days was lower [13.0% (3/23) vs. 40.9% (9/22), P<0.05]. After therapy, patients in CBP group showed more reduction in the APACHEII score compared with control group (3.96±4.07 vs. 1.68±2.43, P<0.05). Patients in control group showed less change in APC, sICAM-1 and vWF. APC in CBP group increased at 72 hours, and sICAM-1 and vWF of CBP group respectively decreased at 24 hours or 72 hours, while the APC (μg/L) and vWF (mg/L) at 72 hours showed significant change compared with that of the control group (15.12±7.57 vs. 10.01±5.83, 1.58±0.73 vs. 2.64±1.34, P<0.05 and P<0.01). In patients who died in 28 days (12 patients) there were little changes in APC, sICAM-1 and vWF, while patients who lived for 28 days (33 patients), showed significantly more reduction in sICAM-1 (μg/L) and vWF (mg/L, 61.03±45.58 vs. 104.64±71.08, 1.88±1.21 vs. 2.70±0.95,both P<0.05). The APC value (μg/L) was increased after treatment in patients who survived for 28 days (13.55±7.11 vs. 10.37±7.60, P<0.01).
  
  
  CONCLUSIONS
  CBP therapy can protect endothelial cell function and ameliorate dysfunction, and it reduces the severity of the severe sepsis as well as improves the outcome of patients with severe sepsis.
authors.affiliation: Critical Care Medical Department, Affiliated Hospital of Binzhou Medical College, Binzhou 256603, Shandong, China.
authors.forename: Sha-Sha
authors.initials: SS
authors.lastname: Han
authors.forename: Ting
authors.initials: T
authors.lastname: Sun
authors.forename: Zhi
authors.initials: Z
authors.lastname: Li
authors.forename: Ling-Zhi
authors.initials: LZ
authors.lastname: Jia
authors.forename: Quan-Mei
authors.initials: QM
authors.lastname: Shang
authors.forename: Xiao-Zhi
authors.initials: XZ
authors.lastname: Wang
mesh_terms: D000328:Adult; D000368:Aged; D042783:Endothelial Cells / Q000502:physiology*; D005260:Female; D006440:Hemofiltration; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011486:Protein C / Q000378:metabolism; D018805:Sepsis / Q000503:physiopathology / Q000628:therapy*; D014841:von Willebrand Factor / Q000378:metabolism
chemical_list: D011486:Protein C; D014841:von Willebrand Factor; D018799:Intercellular Adhesion Molecule-1